ArriVent BioPharma

AVBP

Capitalización de mercado USD 1035 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
126	126 Quantbot Technologies New York	USD 59.3 k	+USD 34.6 k	+1,172	+219%
127	127 Tower Research Capital (TRC) New York	USD 54.2 k	-USD 27.8 k	-941	-38%
128	128 US Bancorp Minneapolis, Minnesota	USD 52.5 k	+USD 8.5 k	+288	+24%
129	129 Royal Bank of Canada Toronto, Ontario, Canada	USD 46 k	+USD 38 k	+1,287	+2,925%
130	130 GF Fund Management Guangzhou, China	USD 30.5 k	-USD 1.24 k	-42	-5%
131	131 Osaic Holdings Scottsdale, Arizona	USD 24.4 k	–	–	–
132	132 Farther Finance Advisors San Francisco, California	USD 21.7 k	-USD 1.18 k	-40	-6%
133	133 Caitong International Asset Management Hong Kong	USD 21.1 k	+USD 17 k	+577	+1,861%
134	134 Arax Advisory Partners Denver, Colorado	USD 19.9 k	+USD 7.2 k	+244	+74%
135	135 GAMMA Investing Foster City, California	USD 15.1 k	+USD 2.24 k	+76	+21%
136	136 Versant Capital Management Phoenix, Arizona	USD 14.7 k	–	–	–
137	137 Pacer Advisors Malvern, Pennsylvania	USD 14 k	+USD 12 k	+407	Nuevas
138	138 Nisa Investment Advisors St. Louis, Missouri	USD 13.6 k	+USD 2.33 k	+79	+25%
139	139 BNP Paribas Asset Management Paris, France	USD 12.8 k	-USD 3.72 k	-126	-26%
140	140 SignatureFD Atlanta, Georgia	USD 12.8 k	–	–	–
141	141 Larson Financial Group St Louis, Missouri	USD 9.6 k	–	–	–
142	142 PNC Financial Services Group Pittsburgh, Pennsylvania	USD 7.43 k	-USD 3.31 k	-112	-34%
143	143 Sterling Capital Management Charlotte, North Carolina	USD 4.62 k	-USD 2.24 k	-76	-36%
144	144 Optiver Holding Amsterdam, Netherlands	USD 3.75 k	-USD 4.43 k	-150	-58%
145	145 EverSource Wealth Advisors Birmingham, Alabama	USD 3.47 k	+USD 2.16 k	+73	+270%
146	146 Allworth Financial Folsom, California	USD 1.84 k	+USD 236	+8	+18%
147	147 Torren Management San Diego, California	USD 1.15 k	–	–	–
148	148 SJS Investment Consulting Sylvania, Ohio	USD 938	+USD 797	+27	Nuevas
149	149 SBI Securities Tokyo, Japan	USD 903	–	–	–
150	150 Parallel Advisors San Francisco, California	USD 834	–	–	–

ArriVent BioPharma AVBP Capitalización de mercado USD 1035 M

ArriVent BioPharma

AVBP

Capitalización de mercado USD 1035 M